asthma
BACKGROUND: Salmeterol, a long-acting beta2 -agonist, and zafirlukast, a       leukotriene receptor antagonist, are both indicated for the treatment of asthma       in adolescent and adult patients.
BACKGROUND: Salmeterol, a long-acting beta2 -agonist, and zafirlukast, a       leukotriene receptor antagonist, are both indicated for the treatment of  @SUBJECT$         @PREDICAT$   @OBJECT$  and adult patients.